Клинички испитувања за ХОБП во Мичиген
23 студии за ХОБП бараат учесници на локации во Мичиген.
Градови во Мичиген
Официјален текст на студијата (англиски)
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Allen Park
- GSK Investigational Site, Detroit
- GSK Investigational Site, Garden City
- и уште 1
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 5.10.2026 · NCT06961214Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, Clarkston
- GSK Investigational Site, Flint
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 5.10.2026 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Ann Arbor
- Research Site, Flint
- Research Site, Southfield
- и уште 1
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 2.10.2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Vitalis Clinical Research Center- Site Number : 8400040, Allen Park
- Bolt Clinical Research- Site Number : 8400086, Brighton
- Henry Ford Hospital- Site Number : 8400058, Detroit
- и уште 1
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 1.10.2026 · NCT07190222WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
- University of Michigan Medical Center, Ann Arbor
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT07558265A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Revive Research Institute, Inc., Southfield
Се регрутираФаза 2
Возраст од 40 до 75 · Сите полови · Ажурирано 25.9.2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- University of Michigan Health System - Ann Arbor- Site Number : 8400090, Ann Arbor
- Veritas Clinical Research- Site Number : 8400007, Madison Heights
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 22.9.2026 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Henry Ford Hospital, Detroit
Се регрутира
Возраст од 40 до 80 · Сите полови · Ажурирано 17.9.2026 · NCT06035120A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Farmington Hills
- Research Site, Garden City
- Research Site, Grand Rapids
Се регрутираФаза 2
Возраст 40 и постари · Сите полови · Ажурирано 9.9.2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Michigan, Ann Arbor
- Henry Ford Health, Detroit
Се регрутираФаза 2
Возраст 40 и постари · Сите полови · Ажурирано 4.9.2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Farmington Hills
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 3.9.2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Ann Arbor
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 3.9.2026 · NCT06878261A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Revival Research Institute, LLC, Dearborn
- AA Medical Research Center, Flint
- Revive Research Institute, Inc., Southfield
- и уште 1
Се регрутираФаза 2/3
Возраст од 35 до 80 · Сите полови · Ажурирано 31.8.2026 · NCT07363694Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Michigan, Ann Arbor
Се регрутираФаза 3
Возраст 40 и постари · Сите полови · Ажурирано 31.7.2026 · NCT06376994eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Allen Park
- GSK Investigational Site, Clarkston
- GSK Investigational Site, Dearborn
Се регрутираФаза 3
Возраст од 40 до 75 · Сите полови · Ажурирано 28.7.2026 · NCT07177339Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
- John D. Dingell VA Medical Center, Detroit, MI, Detroit
Се регрутира
Возраст 60 и постари · Сите полови · Ажурирано 5.6.2026 · NCT04179981SPIROMICS Study of Early COPD Progression (SOURCE)
- University of Michigan, Ann Arbor
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 30 до 55 · Сите полови · Ажурирано 3.6.2026 · NCT05033990Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- John D. Dingell VA Medical Center, Detroit, MI, Detroit
Се регрутира
Возраст од 60 до 89 · Сите полови · Ажурирано 26.5.2026 · NCT02703207Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Henry Ford Hospital - Lung and Pulmonary Care, Detroit
Се регрутира
Возраст од 40 до 80 · Сите полови · Ажурирано 28.4.2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Michigan, Ann Arbor
Се регрутира
Возраст од 40 до 84 · Сите полови · Ажурирано 24.4.2026 · NCT06891755University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
- University of Michigan, Ann Arbor
Се регрутираНабљудувачка студија
Возраст од 50 до 80 · Сите полови · Ажурирано 25.3.2026 · NCT07482475Supporting Evidence-based Responses to Emotional Needs in Emphysema
- Henry Ford Health System, Detroit
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 30.1.2026 · NCT06600126myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Henry Ford Health, Detroit
Се регрутира
Возраст 30 и постари · Сите полови · Ажурирано 6.2.2025 · NCT05204888Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.